Fuse Medical, Inc. (FZMD) Financial Statements (2023 and Earlier)

Company Profile

Business Address 1565 NORTH CENTRAL EXPRESSWAY
RICHARDSON, TX 75080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 5047 - Medical, Dental, and Hospital Equipment and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5531,1871,099844805667
Cash and cash equivalents5531,1871,099844805667
Receivables3,5294,4286,1745,2266,57058
Inventory, net of allowances, customer advances and progress billings8,7366,9817,85611,07610,62725
Inventory8,7366,9817,85611,07610,62725
Other undisclosed current assets6244030324
Total current assets:12,82512,62115,16917,17618,034754
Noncurrent Assets
Property, plant and equipment7183343179
Long-term investments and receivables, including:2,1821,670    
Other undisclosed long-term investments and receivables2,1821,670    
Intangible assets, net (including goodwill)3,2903,1113,1804,193821 
Goodwill1,9731,9731,9732,905821 
Intangible assets, net (excluding goodwill)1,3171,1381,2071,288  
Deposits noncurrent assets     4
Other undisclosed noncurrent assets   761375 
Total noncurrent assets:5,4804,7983,2124,9971,21313
TOTAL ASSETS:18,30417,41918,38122,17319,247767
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,3605,8216,0565,4974,41989
Accounts payable4,4623,2372,7532,7132,58883
Accrued liabilities2,8982,5853,3032,7841,8316
Debt2,4339131,7531,4773,415150
Due to related parties15015015015015077
Other undisclosed current liabilities 364    
Total current liabilities:9,9427,2487,9587,1257,984317
Noncurrent Liabilities
Liabilities, other than long-term debt11,79412,13611,64513,58219,245 
Due to related parties200200    
Business combination, contingent consideration, liability11,59411,93611,64513,58219,245 
Other undisclosed noncurrent liabilities 148    
Total noncurrent liabilities:11,79412,28411,64513,58219,245 
Total liabilities:21,73619,53219,60420,70627,229317
Stockholders' equity
Stockholders' equity attributable to parent(3,432)(2,113)(1,222)1,467(7,982)451
Common stock729731731715672159
Additional paid in capital1,4551,184642 (8,653)3,193
Retained earnings (accumulated deficit)(5,616)(4,028)(2,596)752 (2,901)
Total stockholders' equity:(3,432)(2,113)(1,222)1,467(7,982)451
TOTAL LIABILITIES AND EQUITY:18,30417,41918,38122,17319,247767

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues20,41421,39922,90026,34226,407568
Revenue, net1,055568
Cost of revenue(8,479)(8,695)(11,763)(13,353)(14,582)(204)
Gross profit:11,93612,70411,13712,98911,825364
Operating expenses(14,131)(13,732)(15,487)(14,948)(11,007)(856)
Operating income (loss):(2,196)(1,028)(4,350)(1,958)818(492)
Nonoperating income (expense)625(386)1,815(134)(118)(94)
Debt instrument, convertible, beneficial conversion feature     118
Interest and debt expense(78)(95)(122)(134)43(129)
Other undisclosed income from continuing operations before equity method investments, income taxes 951225,797  
Income (loss) from continuing operations before equity method investments, income taxes:(1,648)(1,414)(2,535)3,571743(715)
Other undisclosed income from continuing operations before income taxes78     
Income (loss) from continuing operations before income taxes:(1,570)(1,414)(2,535)3,571743(715)
Income tax expense (benefit)(18)(19)(781)387  
Net income (loss):(1,588)(1,432)(3,316)3,958743(715)
Other undisclosed net income (loss) attributable to parent    (43)129
Net income (loss) available to common stockholders, diluted:(1,588)(1,432)(3,316)3,958700(586)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):(1,588)(1,432)(3,316)3,958743(715)
Comprehensive income (loss), net of tax, attributable to parent:(1,588)(1,432)(3,316)3,958743(715)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: